Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ROTATEQ SOLUCION ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ROTATEQ SOLUCION ORAL

Approved

STANDARD

ROTATEQ SOLUCION ORAL

Merck Sharp & Dohme B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 18, 2024
Approval ID: 8c680abcf3fc132e
Company: Merck Sharp & Dohme B.V.
Type: Standard

Approval Details

Approval Id: 8c680abcf3fc132e
Drug Cima Aemps Name: ROTATEQ SOLUCION ORAL
Register Number: 06348001IP5
Holder Company Name: Merck Sharp & Dohme B.V.
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/merck-sharp-and-dohme-bv
Authorization Date: 2024-07-18
Dosage Form: SOLUCIÓN ORAL
Dose: Desconocida
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Merck Sharp & Dohme B.V.
Company Detail Path: /organization/merck-sharp-and-dohme-bv

Company Information

Pharmaceutical Company Name: Merck Sharp & Dohme BV
Country Name: Netherlands

Active Ingredients

ROTAVIRUS HUMANO SEROTIPO G2

2,8 U

ROTAVIRUS HUMANO SEROTIPO G1

2,2 U

ROTAVIRUS HUMANO SEROTIPO G3

2,2 U

ROTAVIRUS HUMANO SEROTIPO G4

2 U

ROTAVIRUS HUMANO SEROTIPO P1

2,3 U

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 18, 2024

Approval ID

8c680abcf3fc132e

Type

Standard

Back to CIMA-AEMPS Approvals